Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Sagita Dewi"'
Publikováno v:
Sawala : Jurnal Administrasi Negara. 8:58-73
Tujuan dilakukannya penelitian ini yaitu untuk mengetahui proses formulasi pembentukan Badan Usaha Milik Desa Karya Kusuma Mandiri di Desa Wlahar Wetan Kecamatan Kalibagor Kabupaten Banyumas dilihat dari Peraturan Desa Nomor 9 Tahun 2017 tentang Pend
Publikováno v:
Open Access Macedonian Journal of Medical Sciences, Vol 7, Iss 8 (2019)
Open Access Macedonian Journal of Medical Sciences; Vol 7 No 8 (2019): Apr 30 (OAMJMS); 1353-1355
Open Access Macedonian Journal of Medical Sciences
Open Access Macedonian Journal of Medical Sciences; Vol 7 No 8 (2019): Apr 30 (OAMJMS); 1353-1355
Open Access Macedonian Journal of Medical Sciences
BACKGROUND: Cryptococcus is a common cause of opportunistic infection in HIV-positive patients. While the incidence of this disease has decreased in AIDS-associated cases, cryptococcal infection in immune-competent person has been increased. CASE PRE
Publikováno v:
International Journal of Clinical Trials. 7:18
Background: The aim was to introduce response surface pathway (RSP)-design with skewed starting value and stochastic dose-window to estimate optimal efficacy dose (OED) of BP-C2 after IL-1β stimulation in Atlantic salmon.Methods: 54 healthy smolt of
Autor:
Stig Larsen, Bard Dalhoi, Sagita Dewi, Ola Reiertsen, Kjell E. Bjørnæs, Tor Harald Garberg, Joachim Kaufmann, Trond Holand, Espen Glomsrod, Geir Elvbakken
Publikováno v:
Journal of Clinical Trials.
Background: The aim of this paper is to introduce and evaluate the RSP design with two interventional and one response variable exemplified by estimating minimum efficacy dose (MED) of osteopathic manual therapy (OMT) in treatment of gastroesophageal
Autor:
Sagita Dewi, Stig Larsen, Thora J. Jonasdottir, B. Berlinger, Lars Moe, Veronica Kristiansen, Steen Lindkær-Jensen, T. E. Horsberg
Publikováno v:
Veterinary and Comparative Oncology. 15:118-132
The pharmacokinetic profile, tolerability and efficacy of benzene-poly-carboxylic acids complex with cis-diammineplatinum (II) dichloride (BP-C1) were studied in dogs with mammary cancer. A three-level response surface pathway designed trial was perf
Publikováno v:
Open Access Journal of Clinical Trials
Trond Holand,1 Kristian Ellingsen,2 Sagita Dewi,1,3 Stig Larsen1 1Centre for Epidemiology and Biostatistics, Department of Production Animal Clinical Sciences, Faculty of Veterinary Science, Norwegian University of Life Science, 2Norwegian Veterinary
Autor:
Sagita Dewi, Trond Holand, Joachim Kaufmann, Stig Larsen, Espen Glomsrod, Kjell E. Bjørnæs, Geir Elvbakken, Tor Harald Garberg, Ola Reiertsen, Bard Dalhoi
Publikováno v:
International Journal of Clinical Trials. 6:75
Background: The aim of this paper is to introduce and evaluate the RSP design with two interventional and one response variable exemplified by estimating minimum efficacy dose (MED) of osteopathic manual therapy (OMT) in treatment of gastroesophageal
Autor:
Sagita Dewi, Vichien Srimuninnimit, Yen-Shen Lu, Stig Larsen, Tjakra Manuaba, Steen Lindkær-Jensen
Publikováno v:
The Open Breast Cancer Journal. 5:7-15
An anti-cancer agent containing benzene-poly-carboxylic acids complex with cis-diammineplatinum (II) dichloride (BP-C1) was developed to establish a low toxic and cost effective treatment of breast cancer. The study was aimed to investigate if BP-C1
Publikováno v:
Open Access Journal of Clinical Trials
Trond Holand,1 Sagita Dewi,1,2 Stig Larsen1 1Faculty of Veterinary Medicine and Biosciences, Center for Epidemiology and Biostatistics, University of Life Sciences, Oslo, Norway; 2Bali Indra Hospital, Government of Bali province, Denpasar, Bali, Indo
Publikováno v:
Open Access Journal of Clinical Trials.
Sagita Dewi,1 Veronica Kristiansen,2 Steen Lindkær-Jensen,3,4 Stig Larsen1 1Centre for Epidemiology and Biostatistics, Faculty of Veterinary Medicine and Biosciences, Norwegian University of Life Sciences, Ås, Norway; 2Department of Companion Anima